Skip to search formSkip to main contentSkip to account menu

salvicine

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Telomere repeat binding factor 2 (TRF2) has been increasingly recognized to be involved in DNA damage response and telomere… 
Review
2007
Review
2007
AbstractSalvicine is a novel diterpenoid quinone compound obtained by structural modification of a natural product lead isolated… 
2005
2005
Purpose: Salvicine is a novel DNA topoisomerase II inhibitor with potent anticancer activity. In present study, the effect of… 
2004
2004
Salvicine is a diterpenoid quinone derived from a traditional Chinese medication that has been shown to possess potent in vitro… 
2003
2003
AIM To study the effects of actinomycin D (Act D) on the cytotoxicity and apoptosis elicited by salvicine in human leukemia K562… 
2001
2001
Salvicine (a novel diterpenoid quinone compound) exhibited a marked antitumor activity on human solid tumor cell lines and BALB/c… 
2001
2001
AIM To identify whether DNA topoisomerase II (Topo II) is the primary cellular target of salvicine in Saccharomyces cerevisiae (S… 
2001
2001
AIM To synthesized poly(methoxypolyethyleneglycol cyanoacrylate-co-n-hexadecyl cyanoacrylate) (PEGylated PHDCA) with polyethylene… 
1999
1999
AIM To study the in vitro cytotoxicity of 4,5-seco-5,10-friedo-abieta-3,4-dihydroxy-5(10),6,8,13-tetraene-11, 12-dione (salvicine…